|
Beurs gesloten -
Andere beurzen
|
Voorbeurs 07:46:44 | |||
| 0,6120 EUR | +13,12% |
|
0,6150 | +0,49% |
| 13/07 | AB Science staakt drie klinische studies met masitinib | MT |
| 10/07 | AB Science rationaliseert portefeuille en focust op twee moleculen |  |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +13,12% | -12,32% | -20,83% | -42,05% | -60,16% | -57,14% | -82,44% | -94,87% | -95,58% | 56,34 mln. | |
| -1,87% | -2,29% | -1,38% | +13,92% | +21,39% | +61,14% | +20,85% | +67,22% | +121,63% | 316 mld. | |
| -0,49% | +0,49% | -2,20% | +29,44% | +16,19% | +32,94% | -13,19% | -18,41% | +44,94% | 71,26 mld. | |
| -0,33% | +0,97% | +3,55% | +28,63% | +22,24% | +39,39% | +95,42% | +104,14% | +691,82% | 9,76 mld. | |
| -2,19% | -7,40% | -10,09% | +2,76% | -2,67% | -4,09% | -6,04% | -29,12% | +44,76% | 8,4 mld. | |
| -0,76% | -4,27% | -9,05% | -21,52% | -37,08% | -16,42% | -17,04% | -36,77% | - | 4,29 mld. | |
| +0,14% | +2,22% | +4,55% | -19,65% | -34,52% | -34,69% | +5,14% | +38,09% | +79,14% | 3,83 mld. | |
| -2,35% | -7,01% | -22,98% | +8,11% | +20,26% | -14,99% | +13,53% | -39,17% | - | 3,5 mld. | |
| +3,07% | -2,09% | -4,27% | -3,87% | -7,44% | +29,56% | +44,43% | +71,07% | +100,70% | 2,68 mld. | |
| +0,47% | +6,57% | +2,69% | -10,89% | -11,96% | +0,22% | -2,10% | +69,34% | - | 2,26 mld. | |
| +0,90% | +3,00% | 0,00% | -6,99% | -11,68% | -21,69% | -14,72% | -7,76% | -39,91% | 1,77 mld. | |
| -2,08% | -9,60% | -9,85% | -17,27% | -11,33% | -30,81% | +19,07% | -37,75% | - | 1,7 mld. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1,64 mld. | |
| -2,76% | +6,69% | +20,37% | +56,19% | +166,94% | +219,46% | +1.656,42% | +676,94% | - | 1,24 mld. | |
| +10,68% | +7,76% | +9,02% | -25,54% | -27,52% | +76,96% | +57,54% | +44,26% | +551,91% | 1,4 mld. | |
| +4,08% | +0,80% | -14,94% | -31,73% | -19,60% | -51,32% | -24,88% | - | - | 1,15 mld. | |
| 0,00% | -9,08% | -6,43% | -11,58% | -17,10% | -13,27% | +13,22% | +67,03% | +58,71% | 1,02 mld. | |
| -3,28% | -17,21% | -38,26% | -18,20% | -5,15% | -20,48% | +56,63% | -19,74% | - | 949 mln. | |
| +1,07% | +5,02% | +1,55% | -17,06% | -20,10% | -35,54% | -74,09% | -83,10% | - | 923 mln. | |
| +1,45% | +3,59% | -1,01% | -12,01% | -11,69% | -41,96% | -9,07% | -47,20% | -65,81% | 870 mln. | |
| Gemiddelde | +0,98% | -0,42% | -5,24% | -5,23% | -1,63% | +6,17% | +91,51% | +40,23% | +135,67% | 21,71 mld. | |
| Gewogen gemiddelde per kap. | -1,35% | -1,62% | -1,82% | +15,06% | +18,22% | +50,72% | +20,15% | +50,10% | +119,97% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
